Physician's choice of chemotherapy.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast CancerNCT02492711MacroGenicsPhase 3Completed2021-08-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.